Disarticulation Septoplasty Versus Classical Way (DSARTICULATION)

February 17, 2026 updated by: Hôpital NOVO

Disarticulation Septoplasty Versus Classical Septoplasty: Retrospective Study

The objective of this study is to determine which of the two techniques (disarticulation septoplasty versus open surgery) offers the best functional results for correcting symptomatic deviations of the nasal septum.

More specifically it's about:

  • Compare the improvement in respiratory symptoms between the two techniques
  • Analyze and compare complication rates between the two techniques
  • Evaluate patient satisfaction with aesthetic results (including columella deviation)

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Nowadays, disarticulation septoplasty is recognized as an effective technique for correcting complex septal deviations. It allows better exposure of the nasal septum, which facilitates the correction of severe deformities and reduces post-operative complications. This method is often compared to open surgery, which remains a classic approach but perhaps less suited to cases of severe or complex deviations. This technique makes it possible to correct aesthetic deviations while improving the functional aspect avoiding an open path.

There are several questionnaires, particularly in the field of rhinology, to evaluate the results of this technique on nasal obstruction in an objective and subjective manner, therefore its impact on quality of life as well as its effectiveness on chronic nasal dysfunction caused by deviation of the nasal septum. In this study, in addition to nasal symptoms before and after surgery and postoperative complications, we chose to work with two scores; NOSE score as a valid, reliable and responsive self-report instrument to quantify subjective dysfunction related to nasal obstruction. The other score is NAFEQ score which makes it possible to evaluate the aesthetic and functional outcome after nasal reconstruction.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patient undergoing a new disarticulation septoplasty, or an open approach for nasal obstruction due to a deviated nasal septum, confirmed by endoscopy

Description

Inclusion Criteria:

  • Patient aged 18 and over
  • Patient undergoing a new disarticulation septoplasty, or an open approach for nasal obstruction due to a deviated nasal septum, confirmed by endoscopy
  • Patient operated between 01/01/2023 and 31/12/2025

Exclusion Criteria:

Patient undergoing surgery but with the following medical history (on the day of surgery):

  • Patient with septal perforations
  • Patient with previous nasal septum surgery or cosmetic rhinoplasty
  • Patient with allergic rhinitis
  • Patient with chronic sinusitis
  • Patient with concha bullosa
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine which of the two techniques (disarticulation septoplasty versus open surgery) offers the best functional results to correct symptomatic nasal septum deviations
Time Frame: Before and at least 3 months after the operation
Comparison of functional improvement in nasal breathing between the two techniques (disarticulation septoplasty versus classic septoplasty), using the standardized NOSE score routinely completed by patients pre-operatively and then 3 months post-operation.
Before and at least 3 months after the operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare the functional improvement between the two techniques, using a different tool
Time Frame: Before and at least 3 months after the operation
The functional improvement in nasal breathing between the two techniques will also be assessed using the NAFEQ score, which is also routinely completed pre-operatively and then 3 months after the operation
Before and at least 3 months after the operation
Compare the improvement in respiratory symptoms between the two techniques
Time Frame: Before and at least 3 months after the operation
The improvement in patients' symptoms will be compared between the two techniques using the responses to the NOSE questionnaire and responses 1-6 of the NAFEQ questionnaire.
Before and at least 3 months after the operation
Analyze and compare the complication rates between the two techniques
Time Frame: At day 15 and 3 months after the operation
The number of the following complications will be compared between the two techniques: bleeding up to day 15, infections up to day 15, and septal perforations up to M3. These data will be available in the patient's medical record.
At day 15 and 3 months after the operation
Assess patient satisfaction with aesthetic results (including columellar deviation)
Time Frame: Before and at least 3 months after the operation
Patient satisfaction with aesthetics will be measured using questions 8 to 14 of the NAFEQ questionnaire and then compared between the two techniques preoperatively and 3 months postoperatively.
Before and at least 3 months after the operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hôpital NOVO

Investigators

  • Principal Investigator: Khaled AL TABAA, Hôpital NOVO
  • Principal Investigator: Esthelle MINKA, Hôpital NOVO

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • R. Jankowski, P. Gallet, D.-T. Nguyen, C. Rumeau. Septoplasty by disarticulation. European Annals of Otorhinolaryngology, Head and Neck Diseases, 2020, 137 (5), pp.423-426. (10.1016/j.anorl.2020.07.014). (hal03492978).

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 31, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

February 9, 2026

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CHRD 1925

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nasal Septum Deviation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe